This evidence has conferred a neuroprotective role of TGF-β in Alzheimer’s disease; therefore, re-establishing the alteration of TGF-β1 signaling could be an alternative in the treatment for this and other neurodegenerative diseases [47]. Here, TGFB1 is linked to early-onset autosomal dominant Alzheimer disease.